Canada’s Global Nexus for Pandemics and Biological Threats at McMaster University and the University of Saskatchewan’s Vaccine and Infectious Disease Organization (VIDO) have signed a partnership agreement that brings the two institutions together to accelerate vaccine and drug development, human clinical trials and create new diagnostic tools.
The Global Nexus for Pandemics and Biological Threats is a world leader in responding to the COVID–19 pandemic and in preparing for the next.
The federal funding, announced by Prime Minister Justin Trudeau, comes through the Canada Foundation for Innovation’s (CFI) Exceptional Opportunities Fund.